STANLEY FLEMMING: Open Payments
NPI 1790803443 · UNIVERSITY PLACE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 9 payments from 6 companies in 2025. Trend: 2023 $256 · 2024 $262 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 2 | $174 |
| Teva Pharmaceuticals USA, Inc. | 2 | $157 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Novo Nordisk Inc | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: AUSTEDO XR, Brinsupri, LOKELMA, Ozempic, Arikayce, AMVUTTRA, FARXIGA, REXULTI.
Industry payments across WA — which companies pay providers there.
